NanoString Technologies (NSTG) Set to Announce Quarterly Earnings on Tuesday

NanoString Technologies (NASDAQ:NSTGGet Rating) will be releasing its earnings data after the market closes on Tuesday, May 10th. Analysts expect NanoString Technologies to post earnings of ($0.53) per share for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.

NanoString Technologies (NASDAQ:NSTGGet Rating) last released its quarterly earnings data on Tuesday, March 1st. The biotechnology company reported ($0.64) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.09). NanoString Technologies had a negative net margin of 79.44% and a negative return on equity of 55.40%. The company had revenue of $42.46 million during the quarter, compared to analysts’ expectations of $41.90 million. During the same period last year, the business earned ($0.53) earnings per share. The company’s revenue for the quarter was up 17.1% compared to the same quarter last year. On average, analysts expect NanoString Technologies to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

NASDAQ:NSTG opened at $19.51 on Tuesday. The business’s 50-day moving average is $29.99 and its two-hundred day moving average is $36.57. The company has a debt-to-equity ratio of 1.27, a current ratio of 8.20 and a quick ratio of 7.60. NanoString Technologies has a 12 month low of $18.49 and a 12 month high of $80.64. The firm has a market capitalization of $896.39 million, a PE ratio of -7.65 and a beta of 1.75.

In related news, CFO K Thomas Bailey sold 5,000 shares of NanoString Technologies stock in a transaction dated Thursday, March 10th. The stock was sold at an average price of $33.81, for a total value of $169,050.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO R Bradley Gray sold 8,625 shares of NanoString Technologies stock in a transaction dated Tuesday, March 15th. The stock was sold at an average price of $27.81, for a total value of $239,861.25. The disclosure for this sale can be found here. Insiders sold 33,864 shares of company stock valued at $1,054,146 over the last quarter. Insiders own 2.80% of the company’s stock.

A number of hedge funds have recently modified their holdings of the business. Norges Bank acquired a new position in NanoString Technologies in the fourth quarter valued at approximately $15,692,000. Bank of New York Mellon Corp boosted its stake in NanoString Technologies by 4.7% in the third quarter. Bank of New York Mellon Corp now owns 297,003 shares of the biotechnology company’s stock valued at $14,259,000 after acquiring an additional 13,205 shares during the period. Nuveen Asset Management LLC boosted its stake in NanoString Technologies by 1.9% in the fourth quarter. Nuveen Asset Management LLC now owns 252,332 shares of the biotechnology company’s stock valued at $9,023,000 after acquiring an additional 4,603 shares during the period. Legal & General Group Plc boosted its stake in NanoString Technologies by 19.6% in the fourth quarter. Legal & General Group Plc now owns 94,227 shares of the biotechnology company’s stock valued at $3,979,000 after acquiring an additional 15,424 shares during the period. Finally, Allianz Asset Management GmbH boosted its stake in NanoString Technologies by 5.3% in the fourth quarter. Allianz Asset Management GmbH now owns 84,875 shares of the biotechnology company’s stock valued at $3,584,000 after acquiring an additional 4,293 shares during the period.

Several research analysts have commented on NSTG shares. StockNews.com started coverage on NanoString Technologies in a research report on Thursday, March 31st. They issued a “sell” rating on the stock. Cowen dropped their target price on NanoString Technologies from $65.00 to $50.00 in a research report on Wednesday, April 13th. Canaccord Genuity Group dropped their target price on NanoString Technologies from $50.00 to $37.00 and set a “buy” rating on the stock in a research report on Wednesday, April 13th. JPMorgan Chase & Co. dropped their target price on NanoString Technologies from $85.00 to $70.00 and set an “overweight” rating on the stock in a research report on Wednesday, March 2nd. Finally, Robert W. Baird dropped their target price on NanoString Technologies from $51.00 to $35.00 in a research report on Wednesday, April 13th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and an average price target of $48.13.

NanoString Technologies Company Profile (Get Rating)

NanoString Technologies, Inc develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system.

Featured Stories

Earnings History for NanoString Technologies (NASDAQ:NSTG)

Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.